Keros Therapeutics

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell KROS and other ETFs, options, and stocks.

About KROS

Keros Therapeutics, Inc. operates as a clinical stage biopharmaceutical company. It focuses on the discovery, development and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with unmet medical need. 

CEO
Jasbir S. Seehra
CEOJasbir S. Seehra
Employees
60
Employees60
Headquarters
Lexington, Massachusetts
HeadquartersLexington, Massachusetts
Founded
2015
Founded2015
Employees
60
Employees60

KROS Key Statistics

Market cap
1.44B
Market cap1.44B
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
155.39K
Average volume155.39K
High today
High today
Low today
Low today
Open price
$50.26
Open price$50.26
Volume
0.00
Volume0.00
52 Week high
$68.29
52 Week high$68.29
52 Week low
$24.38
52 Week low$24.38

Analyst ratings

100%

of 6 ratings
Buy
100%
Hold
0%
Sell
0%

KROS Earnings

-$1.23
-$0.82
-$0.41
$0.00
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Q4 FY22
Estimated
per share
Estimated per share
Actual
Expected Mar 8, Pre-Market
ActualExpected Mar 8, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.